Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

lpha1-adrenergic antagonists block 6-nitrodopamine contractions on the rat isolated epididymal vas deferen

Full text
Author(s):
Britto-Junior, Jose [1] ; Ribeiro, Andre [1] ; Ximenes, Luiz [1] ; Lima, Antonio Tiago [1] ; Jacintho, Felipe Fernandes [1] ; Fregonesi, Adriano [1] ; Monica, Fabiola Z. [1] ; Antunes, Edson [1] ; De Nucci, Gilberto [2, 3, 1, 4]
Total Authors: 9
Affiliation:
[1] Univ Estadual Campinas, Fac Med Sci, UNICAMP, Dept Pharmacol, Campinas, SP - Brazil
[2] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, SP - Brazil
[3] Sao Leopoldo Mandic, Fac Med, Dept Pharmacol, Campinas, SP - Brazil
[4] Brazil Univ, Fernandopolis, SP - Brazil
Total Affiliations: 4
Document type: Journal article
Source: European Journal of Pharmacology; v. 915, JAN 15 2022.
Web of Science Citations: 0
Abstract

6-nitrodopamine (6-ND) is released from rat isolated vas deferens and modulates electrical-field stimulation (EFS) contractions of the rat isolated epididymal vas deferens (RIEVD) via a specific receptor which is blocked by tricyclic antidepressants. Here, the effects of selective alpha(1)-adrenergic receptor antagonists on RIEVD contractions induced by 6-ND, dopamine, noradrenaline, adrenaline and EFS were investigated. Doxazosin and tamsulosin (3-10 nM) caused significant rightward shifts of the concentration-response curve to 6-ND, but had no effect on dopamine-, noradrenaline- and adrenaline-induced contractions. Alfuzosin (10 nM) produced rightward shifts on concentration-response curves to all catecholamines. Silodosin (10 nM) and terazosin (100 nM) displaced to the right the noradrenaline, dopamine and adrenaline curves, but higher concentrations of both antagonists (100 and 300 nM, respectively) were required to displace the 6-ND curves. The EFS-induced contractions were significantly inhibited only at the concentrations that the alpha(1)-adrenergic receptor antagonists caused rightward shifts on the 6-ND concentration-response curves. The inhibition of EFS-induced contractions by doxazosin (10 nM), tamsulosin (10 nM), alfuzosin (10 nM), silodosin (100 nM) and terazosin (300 nM), were not observed in RIEVD obtained from animals chronically treated with L-NAME. This work demonstrates that alpha(1)-adrenoceptor antagonists act as 6-ND receptor antagonists in RIEVD, opening the possibility that many actions previously attributed to noradrenaline could be due to 6-ND antagonism. In addition, blockade of the 6-ND receptors by both tricyclic antidepressants and alpha(1)-adrenergic receptor antagonists may represent the common mechanism of action responsible for their therapeutic use in the treatment of premature ejaculation. (AU)

FAPESP's process: 18/24971-9 - Physiological relevance of catecholamines produced by the endothelium
Grantee:Felipe Fernandes Jacintho
Support Opportunities: Scholarships in Brazil - Doctorate (Direct)
FAPESP's process: 17/15175-1 - Modulation of soluble guanylate cyclase and the intracellular levels of cyclic nucleotides in the lower urinary tract and prostate
Grantee:Edson Antunes
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 19/16805-4 - Evaluation of the pathophysiological role of endothelial catecholamines
Grantee:Gilberto de Nucci
Support Opportunities: Research Projects - Thematic Grants